NASH Archives

Best in Biotech 15 Sep 2023

Five latest advancements in NASH research

Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD) - a condition where fat builds up in the liver, potentially causing liver damage or cirrhosis. Despite…

September 15, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 3 May 2023

First drug discovered through 3D bioprinted tissue disease model

Viscient Bio, Inc. has announced it has identified the world's first drug candidate discovered primarily using 3D bioprinted tissue models of disease formed from human cells. The company said it…

May 3, 2023 - 3 minutesmins - By Jim Cornall

More News! 4 Nov 2022

Alimentiv and Summit collaborate to tackle liver disease NASH

Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit Clinical Research, in a bid to tackle non-alcoholic steatohepatitis (NASH). They announced a strategic alliance…

November 4, 2022 - 3 minutesmins - By Liza Laws

More News! 16 Sep 2022

Strategic collaboration for drug to treat NASH, obesity and diabetes announced

A conditional and exclusive license agreement to develop and commercialize a drug to treat nonalcoholic steatohepatitis (NASH), obesity and type 2 diabetes has been agreed. NeuroBo Pharmaceuticals and Dong-A ST…

September 16, 2022 - 4 minutesmins - By Liza Laws

Liver body Promethera decade3d anatomy online 1

News and Trends 5 Jul 2022

Poxel publishes ALD studies

Two preclinical articles have been published in different journals for treatments being developed by French biopharmaceutical company, Poxel. Poxel develops treatments for chronic, serious diseases with metabolic pathophysiology including non-alcoholic…

July 5, 2022 - 3 minutesmins - By Liza Laws

In Depth 2 Mar 2022

Is a Treatment for NASH Finally on the Horizon?

Despite several high-profile trial failures in the field, multiple players are getting close to the approval stage with drug candidates for NASH, a ‘silent killer’ that affects the liver. Non-alcoholic…

March 2, 2022 - 6 minutesmins - By Clara Rodríguez Fernández

Infographics by

26 Jan 2021

Infographic: The Key Role of Imaging in Clinical Trials

Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have emerged as promising biomarkers in clinical trials. This brand new infographic, created in collaboration with…

January 26, 2021 - 2 minutesmins - By Maya Chergova

News and Trends 13 May 2020

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

Patients with the chronic liver disease NASH must now wait even longer for an approved treatment, after French biotech Genfit’s phase III trial of its lead drug candidate elafibranor failed.…

May 13, 2020 - 4 minutesmins - By Helen Albert

nash northsea therapeutics, liver disease, disease modeling

News and Trends 8 Jan 2020

NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial

The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund the end of a phase IIb trial of its lead fatty acid drug to treat…

January 8, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Dec 2019

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M with the addition of new investors, including Innovation Growth Ventures and Pegasus Tech Ventures among…

December 17, 2019 - 2 minutesmins - By Jonathan Smith

HEADER destroyed liver Transcure Kateryna Kon

Treating Liver Diseases: Is This Preclinical Model the Solution?

Liver diseases are on the rise. Although many drug candidates are being developed, preclinical toxicity, drug metabolism and drug-drug interaction studies remain challenging without a predictive model. One company is…

December 4, 2019 - 6 minutesmins - By Larissa Warneck-Silvestrin

Can This Cell Therapy Help Fight the NASH Epidemic?

Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by a fatty liver, inflammation, and liver cell damage. If left untreated, NASH…

November 4, 2019 - 7 minutesmins - By Larissa Warneck-Silvestrin

Interview 30 Jul 2019

The First Approved NASH Therapy?

Genfit is poised to become the first company to get a treatment for NASH to market -- something that could happen as early as 2020, should its late 2019 phase…

July 30, 2019 - 6 minutesmins - By Helen Albert

nash liver fibrosis genfit terns pharmaceuticals organ

News and Trends 25 Jun 2019

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M

The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for the chronic liver disease NASH in China. As part of the deal, Genfit will receive…

June 25, 2019 - 3 minutesmins - By Jonathan Smith

promethera liver failure stem cell therapy

News and Trends 15 Apr 2019

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as jaundice, in patients with acute liver failure, a condition with no effective treatments. A phase…

April 15, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 27 Mar 2019

Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M

After some big failures from its top competitors earlier this year, French company Genfit has done an IPO to prepare the launch of its drug for NASH, a chronic liver…

March 27, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 12 Jun 2018

The European Fight Against NASH, The Silent Liver Disease

Today is the First International NASH Day, and to mark the occasion, we bring you an update on Europe’s efforts to tackle this largely unrecognized liver disease that currently has…

June 12, 2018 - 9 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 23 Jan 2018

NASH Leader goes Pediatric with Clinical Trial Launch in US

The FDA has cleared Genfit to kick off clinical trials to see if its NASH drug, elafibranor, can also help children. Genfit develops diagnostic and therapeutic tools for metabolic and inflammatory diseases,…

January 23, 2018 - 2 minutesmins - By Alex Dale

Best in Biotech 28 Dec 2017

Bored Between the Holidays? Watch these Biotech Videos!

Christmas might have passed, but we have more videos for you to watch on a dreary winter day! Here are our highlights from 2017. It's vacation time! If you've worn…

December 28, 2017 - 4 minutesmins - By Evelyn Warner

Best in Biotech 26 Dec 2017

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

We love hearing from our readers, and we listen to what they like! Here are the long reads from our best biotech articles of 2017. We gave you a list…

December 26, 2017 - 6 minutesmins - By Evelyn Warner

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering